Moreover, the risk of CKD for each additional cumulative month of NSAIDs exposure
(based on DDD) was evaluated any time and within one year prior to ID, including the number
of months of therapy as a continuous variable in the conditional logistic regression model.
Such analysis was performed for NSAIDs, as a whole class, and for oxicams.